In line with the current WHO guidelines, the histological diagnosis of invasive lobular carcinoma is based on H&E morphology and on the immunohistochemical characterization of E‐cadherin and the catenin complex independently from the presence of underlying CDH1 gene mutations [1, 7, 22]. The gene discussed is CDH1; the disease is invasive lobular breast carcinoma.